---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-261688"
form_type: "8-K"
ticker: "IDYA"
cik: "0001676725"
company_name: "IDEAYA Biosciences, Inc."
filed_at: "2023-10-24T23:59:59+00:00"
generated_at: "2026-06-09T14:18:27.078962+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# IDEAYA reports preliminary $511M cash; ATM facility update with $222.5M remaining

## Summary
- Preliminary cash, cash equivalents and marketable securities of $511.1M as of Sept 30, 2023 (unaudited, subject to change).
- Sold 1,036,421 shares under ATM facility at weighted avg price of $26.27 between July 1 and Oct 20, 2023.
- Remaining capacity under ATM facility: approximately $222.5M as of Oct 20, 2023.
- ATM program originally authorized up to $250M, entered into in June 2023.

## SEC filing metadata
- accession: 0001193125-23-261688
- form_type: 8-K
- ticker: IDYA
- cik: 0001676725
- company_name: IDEAYA Biosciences, Inc.
- filed_at: 2023-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676725/000119312523261688/0001193125-23-261688-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676725/000119312523261688/d550842d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-261688
- JSON: https://secwatch.observer/filing/0001193125-23-261688.json
- Plain text: https://secwatch.observer/filing/0001193125-23-261688.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.